Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y Karino

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|May 1, 1993
[Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis]Y Karino
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1994
[Classification of hepatitis C virus into two major groups in serologic activity: correlation with response to interferon]T Matsushima, Y Karino, S Hige, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1994
[Interstitial pneumonia induced by interferon therapy in type C hepatitis]Y Karino, S Hige, T Matsushima, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|March 1, 1993
[Hepatitis C]T Matsushima, Y Karino, S Hige, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|November 1, 1994
Significance of 2',5'-oligoadenylate synthetase activity and HCV genotype in IFN therapy for type C chronic hepatitisY Karino, S Hige, T Matsushima, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Modification of cellular efflux and cytotoxicity of adriamycin by biscoclaulin alkaloid in vitroS Nagaoka, S Kawasaki, Y Karino, et al.
Journal of Gastroenterology|April 25, 2000
Gastric varices with splenic vein occlusion treated by splenic arterial embolizationT Sato, K Yamazaki, J Toyota, et al.
Gastroenterologia Japonica|July 1, 1991
Treatment of chronic non-A, non-B hepatitis with interferonY Karino, T Matsushima, A Saga, et al.
Journal of Gastroenterology|August 5, 1999
Evaluation of magnetic resonance angiography in detection of gastric varicesT Sato, K Yamazaki, J Toyota, et al.
Gastroenterologia Japonica|April 1, 1989
Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitisY Karino, T Sugawara, A Saga, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|May 1, 1993
[Mechanisms of the effect of interferon (IFN) therapy in patients with type B and C chronic hepatitis]Y Karino
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1994
[Classification of hepatitis C virus into two major groups in serologic activity: correlation with response to interferon]T Matsushima, Y Karino, S Hige, et al.
Nihon Rinsho. Japanese Journal of Clinical Medicine|July 1, 1994
[Interstitial pneumonia induced by interferon therapy in type C hepatitis]Y Karino, S Hige, T Matsushima, et al.
Rinsho Byori. the Japanese Journal of Clinical Pathology|March 1, 1993
[Hepatitis C]T Matsushima, Y Karino, S Hige, et al.
[Hokkaido Igaku Zasshi] the Hokkaido Journal of Medical Science|November 1, 1994
Significance of 2',5'-oligoadenylate synthetase activity and HCV genotype in IFN therapy for type C chronic hepatitisY Karino, S Hige, T Matsushima, et al.
European Journal of Cancer & Clinical Oncology|September 1, 1987
Modification of cellular efflux and cytotoxicity of adriamycin by biscoclaulin alkaloid in vitroS Nagaoka, S Kawasaki, Y Karino, et al.
Journal of Gastroenterology|April 25, 2000
Gastric varices with splenic vein occlusion treated by splenic arterial embolizationT Sato, K Yamazaki, J Toyota, et al.
Gastroenterologia Japonica|July 1, 1991
Treatment of chronic non-A, non-B hepatitis with interferonY Karino, T Matsushima, A Saga, et al.
Journal of Gastroenterology|August 5, 1999
Evaluation of magnetic resonance angiography in detection of gastric varicesT Sato, K Yamazaki, J Toyota, et al.
Gastroenterologia Japonica|April 1, 1989
Serum 2'-5'oligoadenylate synthetase as a monitoring marker of anti-viral effect during interferon therapy for chronic type B hepatitisY Karino, T Sugawara, A Saga, et al.
Pageof 3